|
Wang, Jiping; Carvajal-Carmona, Luis G; Chu, Jen-Hwa et al. (2013) Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study. Clin Cancer Res 19:6430-7
|
|
Chan, Andrew T; Hsu, Meier; Zauber, Ann G et al. (2012) The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila) 5:61-72
|
|
Chan, Andrew T; Sima, Camelia S; Zauber, Ann G et al. (2011) C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila) 4:1172-80
|
|
Bertagnolli, Monica M; Hsu, Meier; Hawk, Ernest T et al. (2010) Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) 3:588-96
|
|
Chan, Andrew T; Zauber, Ann G; Hsu, Meier et al. (2009) Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 136:2127-2136.e1
|
|
Bertagnolli, Monica M; Eagle, Craig J; Zauber, Ann G et al. (2009) Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) 2:310-21
|
